Insider trades
Redmile Group, Director of Fate Therapeutics FATE, has filed 17 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $19.6M. The latest trade was on 06/12.
Redmile Group
Director
- Company
- Fate Therapeutics FATE
- First filing
- 23/01/04
- Trades
- 163 trades
- Buys / sales
- 17 / 11
- 12-month net buying
- −$19.6M
- Last trade
- 06/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ADCT | Open-market sale | 03/31–04/02 | 04/02 | 5,880,415 sh6 trades | $3.34avg. | $19,641,066.76 | No record |
| Open-market buy | 24/12/20 | 24/12/26 | 397,964 sh | $1.68 | $668,579.52 | +3.2% | |
| Open-market sale | 24/12/20 | 24/12/26 | 341,633 sh | $1.68 | $573,943.44 | −2.7% | |
ADCT | Open-market buy | 24/12/11 | 24/12/13 | 200,000 sh4 trades | $3.05avg. | $609,000 | No record |
Shattuck LabsSTTK | Open-market buy | 24/12/04 | 24/12/06 | 133,371 sh | $1.25 | $166,713.75 | +2.5% |
Shattuck LabsSTTK | Open-market sale | 24/12/04 | 24/12/06 | 133,371 sh | $1.25 | $166,713.75 | −2.4% |
ADC TherapeuticsADCT | Open-market sale | 24/12/04 | 24/12/06 | 25,352 sh | $2.07 | $52,478.64 | −0.2% |
ADCT | Open-market buy | 24/07/01 | 24/07/03 | 800,000 sh2 trades | $2.81avg. | $2,248,000 | No record |
AbsciABSI | Open-market buy | 24/03/01 | 24/03/05 | 222,222 sh | $4.50 | $999,999 | +2.8% |
| Open-market buy | 23/12/26 | 23/12/28 | 44,630 sh | $3.72 | $166,023.6 | +0.3% | |
| Open-market buy | 23/11/20 | 23/11/22 | 1,500,000 sh2 trades | $4.00avg. | $6,000,000 | No record | |
| Open-market buy | 23/06/29 | 23/07/03 | 80,423 sh | $9.42 | $757,584.66 | +2.8% | |
| Open-market sale | 23/06/29 | 23/07/03 | 80,423 sh | $9.42 | $757,584.66 | −2.7% | |
FATE | Open-market buy | 23/04/20–23/04/21 | 23/04/21 | 276,639 sh2 trades | $6.17avg. | $1,705,829.02 | +2.2% |
| Open-market buyAmendment | 21/10/28 | 23/04/21 | 1,625,000 sh | $4.00 | $6,500,000 | +35.4% | |
| Open-market buy | 23/04/14 | 23/04/17 | 25,700 sh | $6.00 | $154,200 | +0.2% | |
| Open-market sale | 23/04/14 | 23/04/17 | 302,339 sh | $5.84 | $1,765,659.76 | −2.3% |
